In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, heads of regulatory affairs, directors of quality assurance, and commercial directors from AED manufacturers, OEMs, and component suppliers (battery technology, electrode pad makers, software/algorithm developers) were examples of supply-side sources. Cardiologists, emergency medicine doctors, hospital biomedical equipment managers, procurement leads from hospitals and health systems, directors of emergency medical services (EMS), chiefs of fire departments, corporate safety officers, school health administrators, aviation safety managers, and managers of sports facilities were among the demand-side sources. Primary research verified product development pipelines and technology roadmaps, validated market segmentation across end-use settings (hospitals & clinics, pre-hospital EMS, public access defibrillation programs, home care, alternate care facilities), and collected information on clinical efficacy data, pricing strategies, distribution channel dynamics, maintenance service contracts, and regulatory compliance requirements.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Global market valuation was derived through revenue mapping and device deployment volume analysis. The methodology included:
Identification of 40+ key manufacturers across North America, Europe, Asia-Pacific, and Latin America specializing in AED technologies
Product mapping across fully automatic AEDs, semi-automatic AEDs, wearable cardioverter defibrillators (WCDs), and professional/hospital-grade defibrillators
Analysis of reported and modeled annual revenues specific to AED portfolios, including device sales, electrode pad replacements, battery replacements, and service contracts
Coverage of manufacturers representing 75-80% of global market share in 2024
Extrapolation using bottom-up (device deployment volume × ASP by country/region, accounting for public access programs, healthcare facility mandates, and legislative requirements) and top-down (manufacturer revenue validation, distributor channel analysis) approaches to derive segment-specific valuations across product type, end-user, and regional segments
This methodology maintains the structural integrity of your original format while adapting sources and percentages specifically for the AED market's regulatory and stakeholder landscape.